Macrocyclic hepatitis C serine protease inhibitors

The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, o...

Full description

Saved in:
Bibliographic Details
Main Authors SHANLEY JASON P, LIU DONG, SHEIKH AHMAD, GAI YONGHUA, SUN YING, GRIEME TIM, GRAMPOVNIK DAVID J, KU YIYIN, OR YAT SUN, ENGSTROM KEN, MCDANIEL KEITH F, WAGAW SEBLE H, MEI JIANZHANG, KEMPF DALE J, CHEN HUI-JU
Format Patent
LanguageEnglish
Published 10.06.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
AbstractList The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Author WAGAW SEBLE H
LIU DONG
MEI JIANZHANG
SUN YING
CHEN HUI-JU
MCDANIEL KEITH F
SHANLEY JASON P
KEMPF DALE J
KU YIYIN
GAI YONGHUA
GRIEME TIM
GRAMPOVNIK DAVID J
OR YAT SUN
SHEIKH AHMAD
ENGSTROM KEN
Author_xml – fullname: SHANLEY JASON P
– fullname: LIU DONG
– fullname: SHEIKH AHMAD
– fullname: GAI YONGHUA
– fullname: SUN YING
– fullname: GRIEME TIM
– fullname: GRAMPOVNIK DAVID J
– fullname: KU YIYIN
– fullname: OR YAT SUN
– fullname: ENGSTROM KEN
– fullname: MCDANIEL KEITH F
– fullname: WAGAW SEBLE H
– fullname: MEI JIANZHANG
– fullname: KEMPF DALE J
– fullname: CHEN HUI-JU
BookMark eNrjYmDJy89L5WQw8k1MLspPrkzOyUxWyEgtSCzJLMksVnBWKE4tysxLVSgoyi9JTSxOVcjMy8hMyizJLyrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoYGhiYmZgYWjobGxKkCAJfXLvo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2010144608A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2010144608A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:07:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2010144608A13
Notes Application Number: US20090584716
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100610&DB=EPODOC&CC=US&NR=2010144608A1
ParticipantIDs epo_espacenet_US2010144608A1
PublicationCentury 2000
PublicationDate 20100610
PublicationDateYYYYMMDD 2010-06-10
PublicationDate_xml – month: 06
  year: 2010
  text: 20100610
  day: 10
PublicationDecade 2010
PublicationYear 2010
Score 2.7703447
Snippet The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Macrocyclic hepatitis C serine protease inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100610&DB=EPODOC&locale=&CC=US&NR=2010144608A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2K79WsPRVzaMoRuw62yt5GmGSuMbtiK-N97iZ3uaW8hgcsl8LvL5b4AHheqcJaZ6sxFuFk90dV7jtfVPZu5LnNclipHezx0Bon1OrNnDVhtc2FUndAvVRwREcUR75WS15v_T6xAxVaWT2mOU-vnaOoHWm0dm1IjG1rQ98PxKBhRjVI_mWjDN7UmTR_De0Fb6QAf0q7EQ_jel3kpm12lEp3C4RjpFdUZNETRgmO67b3WgqO4dnnjsEZfeQ6dmKHY5N8ceSRLIWOhq7wklJQqh4-omguolUheLPM0l310LuAhCqd0oOPm87-zzpPJLqfdS2gW60JcATF45lhGxmxmydzRjPEFZyjKzI7JjJSJa2jvo3Szf_kWTn7d4g7K5TY0q49PcYfatkrv1SX9AI5Igow
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8NADA9jivNNp-J0akHpW7FdP_dQxPWDqms3XCt7K9ePsYJ0w1bE_97c2eme9nZc4C45-CWXyyUBuFuwwllSIhAd4aYMc1kYaoYsGCrRdaLpJGGBdj_QvEh5nqvzFrxvcmFYndAvVhwREZUi3mumr9f_j1g2-1tZ3ScFTq0e3NC0-cY7lqhFFnl7ZDrTiT2xeMsyoxkfvDIadX1E4xF9pT28ZOsUD87biOalrLeNinsE-1Ncr6yPoZWXXehYm95rXTjwm5A3Dhv0VScw8AmqzfQ7RR65ZU7_QtdFxVlcxXL4OFZzAa0SV5TLIiloH51TuHWd0PIE3Dz-kzWOZtucymfQLldlfg6cmGaaImZEJQrNHc1IukgJCiENJCImJO9Bf9dKF7vJN9DxQn8cj5-Cl0s4_A2Ra6ij-9CuPz7zK7S8dXLNDuwH2VWFfw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Macrocyclic+hepatitis+C+serine+protease+inhibitors&rft.inventor=SHANLEY+JASON+P&rft.inventor=LIU+DONG&rft.inventor=SHEIKH+AHMAD&rft.inventor=GAI+YONGHUA&rft.inventor=SUN+YING&rft.inventor=GRIEME+TIM&rft.inventor=GRAMPOVNIK+DAVID+J&rft.inventor=KU+YIYIN&rft.inventor=OR+YAT+SUN&rft.inventor=ENGSTROM+KEN&rft.inventor=MCDANIEL+KEITH+F&rft.inventor=WAGAW+SEBLE+H&rft.inventor=MEI+JIANZHANG&rft.inventor=KEMPF+DALE+J&rft.inventor=CHEN+HUI-JU&rft.date=2010-06-10&rft.externalDBID=A1&rft.externalDocID=US2010144608A1